Resolvin D3, an omega-3-derived lipid, reversed psoriasis-like itch and skin inflammation in mice by blocking TRPV1 channels and reducing CGRP in sensory neurons — and also worked on human neurons.
Single dose reversed itchOne systemic injection of RvD3 at 2.8 mg/kg reversed established psoriasiform itch in mice
What the researchers found
Resolvin D3 reversed psoriasiform itch and prevented skin inflammation by inhibiting TRPV1 and reducing CGRP in sensory neurons, with confirmed activity in human DRG neurons.
Why it matters
Current psoriasis biologics are expensive and have side effects. A naturally derived molecule that simultaneously addresses both itch and inflammation through neuronal pathways could offer a safer alternative.
The numbers in context
2.8 mg/kg single dose reversed itch; repeated dosing prevented itch + inflammation; reduced CGRP; CGRP knockdown replicated effects; confirmed in human DRG neurons
How the study worked
Mouse imiquimod psoriasis model with behavioral testing, DRG neuron electrophysiology, CGRP knockdown, and translational validation in human DRG neurons. RvD3 administered systemically at 2.8 mg/kg.
Who was studied
Imiquimod psoriasis mice; human DRG neurons
What this study cannot tell us
Mouse model (imiquimod) doesn't perfectly replicate human psoriasis; human data limited to isolated neurons, not clinical psoriasis patients; long-term dosing effects unknown.
How to read the evidence
Moderate — strong mechanistic animal data with human neuron validation, but no clinical trial in psoriasis patients.
When this study was published
Published in 2020; resolvin and CGRP research have both advanced significantly since.
The bigger picture
Resolvins are part of the body's natural inflammation-resolution system. This study connects omega-3 metabolism to the CGRP pathway — the same pathway targeted by migraine drugs — opening new possibilities for treating inflammatory skin diseases.
Questions still open
- Would resolvin D3 be effective in human psoriasis clinical trials?
- Could omega-3 supplementation increase endogenous resolvin D3 levels enough to help psoriasis?
- How does RvD3 compare to CGRP-blocking antibodies already used for migraine?
Common questions
What is resolvin D3?
Could fish oil supplements help psoriasis through this mechanism?
Read the original research
Resolvin D3 controls mouse and human TRPV1-positive neurons and preclinical progression of psoriasis.
Theranostics, 10(26), 12111-12126
Citation
Lee, Sang Hoon; Tonello, Raquel; Im, Sang-Taek; Jeon, Hawon; Park, Jeongsu; Ford, Zachary; Davidson, Steve; Kim, Yong Ho; Park, Chul-Kyu; Berta, Temugin. (2020). Resolvin D3 controls mouse and human TRPV1-positive neurons and preclinical progression of psoriasis.. Theranostics, 10(26), 12111-12126. https://doi.org/10.7150/thno.52135